Thailand introduced and legislated Universal Health Coverage (UHC), “30 baht treats all disease project”, in 2001. The scheme covered approximately 47 million people who were not insured by Thailand\\\'s other existing large scale insurance schemes.This work aims to1) understand how UHC affects and alters households’ routine life decisions, a

HITAP, under the leadership of the National Health Foundation (NHF), Thailand, is partnering with the Saw Swee Hock School of Public Health (SSHSPH), National University of Singapore (NUS) and the Mathematical/Economic Modelling Department (MAEMOD) at the Mahidol Oxford Tropical Medicine Research Unit (MORU) as part of the Asia HTA Consortium

The Prince Mahidol Award Conference (PMAC) is an annual international conference focusing on policy-related health issues. PMAC is co-hosted by the Prince Mahidol Award Foundation with support from other key related partners. In 2021, HITAP has led one webinar session and co-led two others with international partners. For more information, please v

The rapidly evolving healthcare landscape is being shaped by cutting-edge technologies such as big data analytics, digital advancements, and genomics, leading to the emergence of Precision Medicine (PM). National genomics programs worldwide are embracing PM\'s potential, signaling an imminent integration into healthcare systems. However, PM interve

Traditional and complementary medicines (T&CM) have increased in uptake and economic importance globally. T&CM involves the examination, diagnosis, therapy, treatment, disease prevention, and rehabilitation. The World Health Organization\'s (WHO) Traditional Medicine Strategy 2014-2023 outlines a framework for action through the regulation,

HTAsiaLink is a collaborative research network of Health Technology Assessment (HTA) agencies in the Asia-Pacific region established on September 2010. The network started with an aim to strengthen Health Technology Assessment (HTA) research efficiency by sharing HTA information, experiences, and resources within the members. HTAsiaLink also focuse

โรคเบาหวานและภาวะแทรกซ้อนของโรคเบาหวาน เป็นปัญหาสาธารณสุขที่สำคัญระดับโลก ผู้ป่วยเบาหวานทั่วโลกที่มีอายุระหว่าง 20 – 79 ปี ม

In Thailand, the prevalence of chronic kidney disease (CKD) is 17.5% of the population (Ingsathit et al., 2010). According to Thailand’s National Health Security Office (2021), in each year, this public health agency spends approximately 10,000 million Baht in renal dialysis and 1,000 million Baht for the CKD treatment and other related expenses.

Together with the Mahidol Oxford Tropical Medicine Research Unit (MORU), HITAP has been engaged in assisting with building technical capacity for HTA and more broadly, evidence-informed decisions for health care in Laos since 2019. Towards this objective, HITAP hosted researchers from University of Health Sciences (UHS) and Lao-Oxford-Mahosot Hospi